M., Lee, H., Kang, S
It was not until I began focusing solely on menopause medicine that I could finally connect the dots between hormones, metabolism, and midlife weight gain
Liu X, George GC, Tsimberidou AM, Naing A, Wheler JJ, Kopetz S , Fu S, Piha-Paul SA, Eng C, Falchook GS, Janku F, Garrett CR, Karp DD, Kurzrock R, Zinner R, Raghav KPS, Subbiah V, Meric-Bernstam F, Hong DS, Overman MJ
The arrival of GLP-1 medications has been a game-changer in the world of weight management
But there is a need for more research on the semaglutide effects on cardiovascular morbidity and mortality among those with obesity but without diabetes
The rising prevalence of type 2 diabetes and obesity, increasing adoption for chronic weight management among non-diabetic populations, expansion of pharmaceutical R&D pipelines, and growing demand in emerging markets with high metabolic disease burden are key drivers of market growth